Medtronic plc — Director's Dealing 2023

Aug 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2023-07-31

Reporting Person: Kirk Jennifer M (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-31	Ordinary Shares	A	2849	—	Acquired	13376	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-31	Performance Share Units	$	A	7122	Acquired		Performance Share Unit (7122)	Direct
2023-07-31	Stock Option (Right to Buy)	$87.76	A	20058	Acquired	2033-07-31	Ordinary Shares (20058)	Direct

Footnotes

F1: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.

F2: Includes 114 units acquired through dividend reinvestment and 298 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

F3: This performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 7,122 shares will be issued. If maximum performance metrics are achieved, 14,244 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F5: Vests on July 31, 2026.

F6: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.